Impairment of neurocognitive function in brain metastases patients: baseline results from the phase III trial with motexafin gadolinium Article

Mehta, MP, Rodrigus, P, Terhaard, CH et al. (2001). Impairment of neurocognitive function in brain metastases patients: baseline results from the phase III trial with motexafin gadolinium . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 51(3), 135-136. 10.1016/s0360-3016(01)02070-3

cited authors

  • Mehta, MP; Rodrigus, P; Terhaard, CH; Rao, A; Suh, J; Roa, W; Souhami, L; Bezjak, A; Leibenhaut, M; Komaki, R; Schultz, CJ; Timmerman, R; Illidge, T; Meyers, CA; Curran, WJ; Phan, SC; Smith, J; Renschler, MF

authors

publication date

  • November 1, 2001

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3211 Oncology and Carcinogenesis

Digital Object Identifier (DOI)

publisher

  • Elsevier

start page

  • 135

end page

  • 136

volume

  • 51

issue

  • 3